Cargando…

Dystrophin Is a Tumor Suppressor in Human Cancers with Myogenic Programs

Many common human mesenchymal tumors, including gastrointestinal stromal tumor (GIST), rhabdomyosarcoma (RMS), and leiomyosarcoma (LMS), feature myogenic differentiation(1–3). Here we report that intragenic deletion of the dystrophin-encoding and muscular dystrophy-associated DMD gene is a frequent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuexiang, Marino-Enriquez, Adrian, Bennett, Richard R., Zhu, Meijun, Shen, Yiping, Eilers, Grant, Lee, Jen-Chieh, Henze, Joern, Fletcher, Benjamin S., Gu, Zhizhan, Fox, Edward A., Antonescu, Cristina R., Fletcher, Christopher D.M., Guo, Xiangqian, Raut, Chandrajit P., Demetri, George D., van de Rijn, Matt, Ordog, Tamas, Kunkel, Louis M., Fletcher, Jonathan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225780/ https://www.ncbi.nlm.nih.gov/pubmed/24793134 http://dx.doi.org/10.1038/ng.2974

Ejemplares similares

Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
por: Heinrich, Michael C., et al.
Publicado: (2019)

MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation
por: Schaefer, Inga-Marie, et al.
Publicado: (2017)

Morpholino Oligomer-Induced Dystrophin Isoforms to Map the Functional Domains in the Dystrophin Protein
por: Li, Dunhui, et al.
Publicado: (2020)

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
por: Serrano, César, et al.
Publicado: (2019)

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
por: Serrano, César, et al.
Publicado: (2019)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
por: Greer, Kane L, et al.
Publicado: (2014)

Multiple exon skipping strategies to by-pass dystrophin mutations
por: Adkin, Carl F., et al.
Publicado: (2012)

Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD
por: Górecki, Dariusz C.
Publicado: (2022)

To dystrophin and beyond: an interview with Louis Kunkel
por: Kunkel, Louis M.
Publicado: (2019)

Antisense suppression of donor splice site mutations in the dystrophin gene transcript
por: Fletcher, Sue, et al.
Publicado: (2013)

Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene
por: Greer, Kane, et al.
Publicado: (2020)

Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries
por: Adams, Abbie M, et al.
Publicado: (2007)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
por: Fletcher, Sue, et al.
Publicado: (2012)

Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
por: Fragall, Clayton T, et al.
Publicado: (2011)

Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells
por: Luo, Yue-Bei, et al.
Publicado: (2014)

The expression of myogenic regulatory factors and muscle growth factors in the masticatory muscles of dystrophin-deficient (MDX) mice
por: Spassov, Alexander, et al.
Publicado: (2011)

Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations
por: Luce, Leonela N., et al.
Publicado: (2016)

Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
por: He, Ruojie, et al.
Publicado: (2020)

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
por: Toh, Zhi Yon Charles, et al.
Publicado: (2016)

Effect of serotonin modulation on dystrophin-deficient zebrafish
por: Spinazzola, Janelle M., et al.
Publicado: (2020)

CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy
por: Domenig, Seraina A., et al.
Publicado: (2022)

mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies
por: Falzarano, Maria Sofia, et al.
Publicado: (2023)

E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non–small cell lung cancer
por: Li, Ke, et al.
Publicado: (2021)

Dystrophins and dystrobrevins
por: Roberts, Roland G
Publicado: (2001)

Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing
por: Bennett, Richard R, et al.
Publicado: (2001)

The importance of dystrophin and the dystrophin associated proteins in vascular smooth muscle
por: Kaplan, Katherine M., et al.
Publicado: (2022)

YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways
por: Ou, Wen-Bin, et al.
Publicado: (2021)

Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
por: Meng, Jinhong, et al.
Publicado: (2020)

Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin
por: Wang, Hong, et al.
Publicado: (2021)

Hybrid Schwannoma-Perineurioma Frequently Harbors VGLL3 Rearrangement
por: Dickson, Brendan C., et al.
Publicado: (2021)

The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma
por: Wu, Xinqi, et al.
Publicado: (2012)

Assembly of the Dystrophin-Associated Protein Complex Does Not Require the Dystrophin Cooh-Terminal Domain
por: Crawford, Gregory E., et al.
Publicado: (2000)

Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020)

Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategies
por: Li, George Z, et al.
Publicado: (2019)

A delayed and recurrent pneumothorax complicating a fractured clavicle – A novel presentation()
por: Fletcher, Cary, et al.
Publicado: (2020)

Effect of Ataluren on dystrophin mutations
por: Berger, Joachim, et al.
Publicado: (2020)

Dystrophin genetic variants and autism
por: Passos-Bueno, Maria Rita, et al.
Publicado: (2022)

Subcellular Localization of Dystrophin Isoforms in Cardiomyocytes and Phenotypic Analysis of Dystrophin-deficient Mice Reveal Cardiac Myopathy is Predominantly Caused by a Deficiency in Full-length Dystrophin
por: Masubuchi, Nami, et al.
Publicado: (2013)

Failure to define level 1 care
por: Fletcher, B, et al.
Publicado: (2011)

Management of Recurrent Retroperitoneal Sarcoma
por: Jolissaint, Joshua S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jgph650l3j80a7tl1ts0m6dtc2